XML 64 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income (loss) $ 184,638 $ (89,778) $ (37,410)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 171,969 168,288 172,301
Gain on acquisition (167,864) 0 0
Gains on sales of properties (13,291) (6,557) (14,613)
Debt satisfaction (gains) charges, net 8,062 311 (3,590)
Impairment charges and loan losses 9,969 117,443 56,940
Straight-line rents (7,372) (1,763) 862
Other non-cash income, net (1,139) (6,364) (7,912)
Equity in earnings of non-consolidated entities (21,531) (30,334) (21,741)
Distributions of accumulated earnings from non-consolidated entities, net 7,498 11,549 3,233
Deferred taxes, net (186) (1,799) 489
Increase (decrease) in accounts payable and other liabilities (598) 1,589 5,186
Change in rent receivable and prepaid rent, net (1,325) 19,929 12,272
Increase (decrease) in accrued interest payable (2,473) (970) 2,921
Other adjustments, net (2,547) (1,407) (4,187)
Net cash provided by operating activities: 163,810 180,137 164,751
Cash flows from investing activities:      
Investment in real estate, including intangible assets (98,083) (25,811) (17,250)
Investment in real estate under construction (113,262) (69,755) (11,258)
Capital expenditures (49,952) (32,426) (35,074)
Acquisition of remaining interest in NLS (9,438) 0 0
Net proceeds from sale of properties 155,240 124,039 80,224
Principal payments received on loans receivable 6,841 46,867 12,480
Investment in loans receivable (11,470) (32,591) (40,632)
Investments in and advances to non-consolidated entities, net (20,172) (19,940) 0
Proceeds from sale of interest in non-consolidated entity 7,000 0 112
Distributions from non-consolidated entities in excess of accumulated earnings 351 5,900 1,356
Increase in deferred leasing costs (14,826) (15,870) (5,129)
Change in escrow deposits and restricted cash 5,710 (3,405) (8,282)
Real estate deposits (149) (1,821) (1,330)
Net cash used in investing activities (142,210) (24,813) (24,783)
Cash flows from financing activities:      
Dividends to common and preferred shareholders (103,295) (94,861) (77,252)
Repurchase of exchangeable notes (62,150) 0 (25,493)
Proceeds from convertible notes 0 0 115,000
Conversion of convertible notes (2,427) 0 0
Principal amortization payments (31,252) (31,068) (33,781)
Principal payments on debt, excluding normal amortization (288,094) (105,266) (331,295)
Change in revolving credit facility borrowing, net 0 0 (7,000)
Increase in deferred financing costs (6,431) (4,214) (5,760)
Proceeds of mortgages and notes payable 121,000 15,000 59,769
Proceeds from term loans 255,000 0 0
Contributions from noncontrolling interests 889 2 4,854
Cash distributions to noncontrolling interests (35,381) (5,811) (8,356)
Repurchase of preferred shares (70,000) (15,456) 0
Receipts (payments) on forward equity commitment, net 0 (2,313) 1,473
Issuance of common shares, net 162,747 99,730 166,652
Net cash used in financing activities (59,394) (144,257) (141,189)
Cash acquired in acquisition of remaining interest in NLS 8,107 0 0
Change in cash and cash equivalents (29,687) 11,067 (1,221)
Cash and cash equivalents, at beginning of year 63,711 52,644 53,865
Cash and cash equivalents, at end of year $ 34,024 $ 63,711 $ 52,644